To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms. The main policy domain is Trade, Healthcare, Defense.
Who Benefits and How
importers, exporters, and commercial firms may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, importers, exporters, and commercial firms may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H5FE9B255434647919FF429EAA9602982: 1. Short title This Act may be cited as the Safe Medicine Act.
- Section H737763DF1C2947C6B2CF1ED5381C2D37: 2. Findings Congress finds the following: Following the enactment of the Drug Price Competition and Patent Term Restoration Act of 1984 (Public Law 98–417),...
- Section HA0CA96FCE475423EB9B0130A81256EBC: 3. Domestic manufacturing to end over-dependence of the United States on Chinese drugs The Secretaries of Health and Human Services, Defense, and Veterans...
- Section H62C6B9981DFF49F5BFF4E8443FD28463: 4. Requiring boxed warnings on potentially contaminated drugs The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs,...
- Section H1DF276CB438547A0A6F51AA3A98C8F7B: 5. Limitation on waiver authority under the Trade Agreements Act of 1979 Section 301 of the Trade Agreements Act of 1979 (19 U.S.C. 2511) is amended by adding...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Key Policy Areas
Trade, Healthcare, Defense
Primary Purpose
This bill, To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Policy Domains
Whole bill
Identified Gains
- importers, exporters, and commercial firms
Identified Costs
- federal implementing agencies
- importers, exporters, and commercial firms
Sponsors
Legislative Progress
IntroducedMr. Posey introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
medicine— that is needed to protect the American public at all times, including from outbreaks of emerging infectious diseases, such as COVID–19, as well as chemical, biological, radiological, and nuclear threats
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology